Simultaneous Determination of Carbamazepine and Carbamazepine-10,11-epoxide in Different Biological Matrices by LC-MS/MS

1. Ettinger AB, Argoff CE. Use of Antiepileptic Drugs for Nonepileptic Conditions: Psychiatric Disorders and Chronic Pain. Neurotherapeutics. 2007;4:75-83.10.1016/j.nurt.2006.10.003Search in Google Scholar

2. Brodie MJ. Antiepileptic drug therapy the story so far. Seizure. 2010;19:650-655.10.1016/j.seizure.2010.10.027Open DOISearch in Google Scholar

3. Kerr BM, Thummel KE, Wurden CJ, et al. Human liver carbamazepine metabolism. Biochem Pharmacol. 1994;47:1969-1979.10.1016/0006-2952(94)90071-XOpen DOISearch in Google Scholar

4. Johannessen SI, Landmark CJ. Antiepileptic drug interactions - principles and clinical implications. Curr Neuropharmacol. 2010;8:254-267.10.2174/157015910792246254300121821358975Search in Google Scholar

5. Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs - Best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49:1239-1276.10.1111/j.1528-1167.2008.01561.x18397299Search in Google Scholar

6. Johannessen SI, Battino D, Berry DJ, et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit. 2003;25:347-363.10.1097/00007691-200306000-0001612766564Open DOISearch in Google Scholar

7. Neels HM, Sierens AC, Naelaerts K, Scharpé SL, Hatfield GM, Lambert WE. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Vol. 42, Clinical Chemistry and Laboratory Medicine; 2004. p. 1228-1255.10.1515/CCLM.2004.24515576287Search in Google Scholar

8. Kim K-B, Seo K-A, Kim S-E, Bae SK, Kim D-H, Shin J-G. Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal. 2011;56:771-777.10.1016/j.jpba.2011.07.01921840666Search in Google Scholar

9. Zhu Y, Chiang H, Wulster-Radcliffe M, et al. Liquid chromatography/tandem mass spectrometry for the determination of carbamazepine and its main metabolite in rat plasma utilizing an automated blood sampling system. J Pharm Biomed Anal. 2005;38:119-125.10.1016/j.jpba.2004.11.05815907629Search in Google Scholar

10. Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP, Hillaire-Buys D. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J Chromatogr B Anal Technol Biomed Life Sci. 2005;828:80-90.10.1016/j.jchromb.2005.09.01916203183Search in Google Scholar

11. Subramanian M, Birnbaum AK, Remmel RP. High-Speed Simultaneous Determination of Nine Antiepileptic Drugs Using Liquid Chromatography-Mass Spectrometry. Ther Drug Monit. 2008;30:347-356.10.1097/FTD.0b013e3181678ecb18520607Open DOISearch in Google Scholar

12. Theodore WH, Narang PK, Holmes MD, Reeves P, Nice FJ. Carbamazepine and its epoxide: Relation of plasma levels to toxicity and seizure control. Ann Neurol. 1989;25:194-196.10.1002/ana.4102502152919868Open DOISearch in Google Scholar

13. Burianová I, Bořecká K. Routine therapeutic monitoring of the active metabolite of carbamazepine: Is it really necessary? Clin Biochem. 2015;48:866-869.Search in Google Scholar

14. Krasniqi S, Zeitlinger M, Bauer S. Comparison between the immunoassay and high performance liquid chromatography for therapeutic monitoring of carbamazepine and phenytoine. Biochem Medica. 2010;341-349.10.11613/BM.2010.044Open DOISearch in Google Scholar

15. Ferreira A, Rodrigues M, Oliveira P, et al. Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine. J Chromatogr B Anal Technol Biomed Life Sci. 2014;971:20-29.10.1016/j.jchromb.2014.09.01025261836Search in Google Scholar

16. Shokry E, Villanelli F, Malvagia S, et al. Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry. J Pharm Biomed Anal. 2015;109:164-170.10.1016/j.jpba.2015.02.04525770414Search in Google Scholar

17. Đorđević S, Kilibarda V, Stojanović T. Determination of carbamazepine in serum and saliva samples by high performance liquid chromatography with ultraviolet detection Odre đ ivanje karbamazepina u uzorcima seruma i salive primenom te č ne hromatografije visokih performansi sa ultravioletnom de. Vojn Pregl. 2009;66:347-352.10.2298/VSP0905347D19489468Search in Google Scholar

18. Krasowski MD, McMillin GA. Advances in anti-epileptic drug testing. Clin Chim Acta. 2014;436:224-236.10.1016/j.cca.2014.06.00224925169Search in Google Scholar

19. Beig A, Dahan A. Quantification of carbamazepine and its 10,11-epoxide metabolite in rat plasma by UPLC-UV and application to pharmacokinetic study. Biomed Chromatogr. 2014;28:934-938.10.1002/bmc.309524327551Open DOISearch in Google Scholar

20. Ates Z, Oezden T, Oezilhan S, Toptan S. Simultaneous determination of carbamazepine and its active metabolite carbamazepine-10,11-epoxide in human plasma by UPLC. Chromatographia. 2007;66:S123-S127.10.1365/s10337-007-0299-2Open DOISearch in Google Scholar

21. Nunes LAS, Mussavira S, Bindhu OS. Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review. Biochem Med (Zagreb). 2015;25:177-192.10.11613/BM.2015.018447010726110030Search in Google Scholar